PacificHealth Laboratories Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PacificHealth Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014336
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PacificHealth Laboratories Inc (PacificHealth) is a healthcare products provider that develops and commercializes patented nutrition products. The company’s products comprise endurox r4, accelerade, accelerade hydro, accel gel, endurox excel, 2nd surge and accel recover. Its dietary and nutritional supplements are used in muscle endurance and appetite regulation. PacificHealth’s endurox r4 is used to reduce muscle damage and increase both muscle function and endurance. The company’s endurox excel forms endurance, speeds up workout recovery and increases lactate threshold. It markets its products in the US and abroad. PacificHealth is headquartered in Matawan, New Jersey, the US.

PacificHealth Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PacificHealth Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 9
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
PacificHealth Labs Enters Into Licensing Agreement With Body Glove International 11
Equity Offering 12
PacificHealth Labs Completes Private Placement Of Preferred Stock For US$1 Million 12
PacificHealth Labs Completes Private Placement Of Units For US$0.1 Million 13
PacificHealth Labs Completes Private Placement For US$0.45 Million 14
PacificHealth Laboratories Inc – Key Competitors 15
PacificHealth Laboratories Inc – Key Employees 16
PacificHealth Laboratories Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PacificHealth Laboratories Inc, Deals By Therapy Area, 2011 to YTD 2017 8
PacificHealth Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 9
PacificHealth Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PacificHealth Labs Enters Into Licensing Agreement With Body Glove International 11
PacificHealth Labs Completes Private Placement Of Preferred Stock For US$1 Million 12
PacificHealth Labs Completes Private Placement Of Units For US$0.1 Million 13
PacificHealth Labs Completes Private Placement For US$0.45 Million 14
PacificHealth Laboratories Inc, Key Competitors 15
PacificHealth Laboratories Inc, Key Employees 16

★海外企業調査レポート[PacificHealth Laboratories Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kadant Inc. (KAI):企業の財務・戦略的SWOT分析
    Kadant Inc. (KAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tecomet Inc:医療機器:M&Aディール及び事業提携情報
    Summary Tecomet Inc (Tecomet) is a medical equipment company that manufactures and markets cases, implants and instruments. The company offers various implants which include acetabular cups, femoral heads, femoral stems, poly liners, femoral wraps, patellas, poly inserts, tibia trays, hooks, plates, …
  • Shoppers Drug Mart Corporation:企業の戦略・SWOT・財務情報
    Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report Summary Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AxoGen Inc (AXGN):企業の財務・戦略的SWOT分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Eni SpA (ENI):石油・ガス:M&Aディール及び事業提携情報
    Summary Eni SpA (Eni) is an integrated oil and gas company that carries out oil and natural gas exploration, field development and production activities. It is also involved in supply, trading and shipping of natural gas, LNG, electricity and fuels. The company has operations in Italy, Cyprus, the U …
  • Hanmi Pharmaceuticals Co Ltd (128940)-製薬・医療分野:企業M&A・提携分析
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • TiVo Corp.:企業の戦略・SWOT・財務情報
    TiVo Corp. - Strategy, SWOT and Corporate Finance Report Summary TiVo Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Aeroflot Oao
    Aeroflot Oao - Strategy, SWOT and Corporate Finance Report Summary Aeroflot Oao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Gentex Corporation:企業の戦略・SWOT・財務情報
    Gentex Corporation - Strategy, SWOT and Corporate Finance Report Summary Gentex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ConCardis GmbH:企業の戦略・SWOT・財務情報
    ConCardis GmbH - Strategy, SWOT and Corporate Finance Report Summary ConCardis GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Pudumjee Paper Products Limited:企業の戦略・SWOT・財務分析
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Camellia PLC (CAM):企業の財務・戦略的SWOT分析
    Summary Camellia Plc (Camellia) is a provider of business processing services. The company operates business through agriculture, food service, engineering and investment sectors. Camellia’s agriculture business division offers products such as rubber, maize, citrus, soya and barley, wine, pineapple …
  • Tessa Therapeutics Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that develops and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response to identify and exterminate cancer cells. The company provides products for various c …
  • Sutro Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sutro Biopharma Inc (Sutro), formerly Fundamental Applied Biology Inc, discovers and develops antibody drug conjugate and multi-specific antibody-based therapeutics. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system, for the treatme …
  • Duke Energy Corporation (DUK):電力:M&Aディール及び事業提携情報
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • Systemax Inc.:企業の戦略・SWOT・財務情報
    Systemax Inc. - Strategy, SWOT and Corporate Finance Report Summary Systemax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Columbia Banking System Inc:企業の戦略・SWOT・財務情報
    Columbia Banking System Inc - Strategy, SWOT and Corporate Finance Report Summary Columbia Banking System Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nascent Biotech Inc (NBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Nascent Biotech Inc (Nascent) is a clinical-stage biopharmaceutical company. The company delivers human monoclonal antibodies and cytokine for the treatment of cancer and drug discovery platform for identifying new antibodies and antigens for commercialization. It develops Pritumumab, a mono …
  • Bio Blast Pharma Ltd (ORPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆